Dangerous Drug News

Side Effect Information About Dangerous Drugs and Medical Devices

Altrumedia
  • Home
  • About
  • Dangerous Drug News
  • Drugs
    • Fluoroquinolone Antibiotics
    • Pradaxa
    • Proton Pump Inhibitors
    • Risperdal
    • Talcum Powder
    • Taxotere
    • Xarelto
    • Zofran
  • Medical Devices
    • Essure
    • IVC Filters
    • Power Morcellators
    • Transvaginal Mesh
  • Free Case Evaluation

Type 2 Diabetes Drugs Pose Numerous Health Risks

June 6, 2019 By Lynn Fugaro Leave a Comment

Diabetic Man Testing Blood Levels

The hits just keep coming for Johnson & Johnson, and now its Type 2 diabetes drug, Invokana, is in the spotlight, again.

Invokana, Invokamet, Farxiga, and Xigduo are in a newer class of diabetes drugs called “sodium-glucose co-transporter 2 (SGLT2) inhibitors”. These drugs are designed to lower blood sugar in people with Type 2 Diabetes by preventing glucose from being reabsorbed into the blood by the kidneys. With these drugs, glucose is instead excreted through the kidneys in urine. The generic drug name for Invokana and Invokamet is canagliflozin, and the generic drug name for Farxiga and Xigduo is dapagliflozin.

Over the past several months, these drugs have been linked to a condition known as Fournier’s gangrene, which is a necrotizing fasciitis of the peritoneum, also known as gangrene of the genitals.  As SGLT2 inhibitors prompt the kidneys to remove sugar from the body through urine, the sugary urine leaves the body but creates the perfect environment for bacteria to grow.

With the favorable environment for bacteria grow, Fournier’s gangrene can occur if there’s a nick in the skin from shaving. A painful infection may affect the perineum, scrotum, or penis and may cause scrotum pain and redness. There may be a foul odor in the area, and the condition can lead to dehydration and anemia.

Invokana (and others) May Lead to Other Serious Health Risks

According to the Food and Drug Administration (FDA), the SGLT2 drugs (Invokana, Invokamet, Farxiga, and Xigduo) have been linked to other serious adverse health conditions; Invokana is already the subject of litigation that alleges it causes severe kidney damage including diabetic ketoacidosis. Now, there’s new evidence that these drugs may lead to a risk of foot and leg amputations in addition to these already-known risks:

  • Ketoacidosis
  • Heart attack
  • Bone fracture
  • Kidney failure

Acute Kidney Failure and Type 2 Diabetes Drugs

With acute kidney failure, the kidneys suddenly stop filtering waste products from your blood, which may cause a buildup of toxins. Acute kidney failure often requires hospitalization and can be fatal if not treated quickly and properly. While some people fully recover from acute kidney failure with proper treatment, many people are left with permanent, serious injuries.

Symptoms of acute kidney damage include:

  • Decreased urine output
  • Fluid retention
  • Swollen legs and feet
  • Fatigue
  • Drowsiness
  • Confusion
  • Nausea
  • Shortness of breath
  • Chest pain
  • Pressure in the chest
  • Seizures in the most serious cases
  • Coma in the most serious cases

New Concern, FDA Warns

In May 2019, the FDA required Johnson & Johnson to add new warnings to the Ivokana label about the risk of foot and leg amputations. The results from two clinical trials showed leg and foot amputations occurred about twice as often in patients with Type 2 diabetes treated with Invokana as those given a placebo, the FDA announced on its website recently.
It’s estimated that over 29 million suffer with Type 2 diabetes in the United States, alone. If you have taken one of these dangerous drugs, please find a product liability attorney in your area who handles difficult defective product cases. Also, if you’re taking one of these drugs, do not stop taking the drug without first speaking to your physician. Not all drugs can be abruptly stopped safely.

Share this:

  • Facebook
  • LinkedIn
  • Twitter

Filed Under: Dangerous Drug, Invokana

Avatar

About Lynn Fugaro

Lynn has been writing web content since 2007 after a lengthy career as a middle school English teacher and administrator. Writing web content seemed a natural progression following a career teaching adolescents about the beauty and the power of the written word, and she quickly got hooked on the challenge of writing SEO- and reader-friendly content that could be found on Page 1 of Google and other search engines.

Having written content for physicians and attorneys for the first few years of her writing career, Lynn has most recently produced original, informative, entertaining, and relevant content for the entertainment industry, the automotive industry, senior communities, pet rescues and numerous other businesses hoping to increase website traffic and page views for all clients looking for informative, vibrant content.

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

RSS FDA Med Watch

  • Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging
  • Angiographic Catheter Recall: Cook Removes Beacon Tip Angiographic Catheters due to Tip Separation
  • mRNA COVID-19 Vaccines: FDA Safety Communication - FDA Approves Required Updated Warning in Labeling Regarding Myocarditis and Pericarditis Following Vaccination
  • Early Alert: Esophageal pH Monitoring Capsule Issue from Medtronic
  • Flexible Tracheostomy Tube Recall: Medtronic Removes Shiley Adult Flexible Tracheostomy Tube with TaperGuard Cuff Reusable Inner Cannula Due to Risk for Disconnection of the Flange from the Device Cannula
  • Import Alerts for Certain Olympus Medical Devices Manufactured in Japan - Letter to Health Care Providers
  • Medical Procedure Kits Correction: Medline Industries, LP Issues Correction for Medline Procedure Kits Containing Medtronic Aortic Root Cannula due to Potential Excess Material in Male Luers

Recent Headlines

Diabetic Man Testing Blood Levels

Type 2 Diabetes Drugs Pose Numerous Health Risks

The hits just keep coming for Johnson & Johnson, and now its … [Read More...]

PPIs Side Effects

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

Proton pump inhibitors (PPIs) are used to treat heartburn, … [Read More...]

Johnson & Johnson Loses Second Major Talcum Powder Case

In its second trial loss in less than 3 months, Johnson & … [Read More...]

Find an Attorney

RSS US Recall News

  • Belviq Withdrawn Due to Cancer Risk
  • Common Heartburn Medication may lead to bladder, stomach, and other cancers. Zantac Lawsuits begin.
  • J&J Settles Talc Mesothelioma Settlement

RSS Lawsuits and Settlements

  • Possible Lawsuit: Suboxone Tooth Decay Legal News and Lawsuit Information
  • Possible Lawsuit: Ozempic and Mounjaro Weight Loss Lawsuit News and Legal Information
  • Possible Lawsuit: CPAP Lung Cancer Lawsuit News and Legal Information

RSS Mass Tort News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Health Industry

  • Feds Prevail Over J&J In Another 340B Rebate Dispute
  • DC Circ. Backs NLRB Ruling In GWU Hospital Bargaining Case
  • Sam's Club Lifting Work Caused Miscarriage, Ex-Worker Says

ABOUT US

DRUG INFO

DEVICES

CASE REVIEW

NEWS

Copyright © 2025 DangerousDrugNews.com · Site Map - Website Development by Altrumedia · Log in